Pharmacoflash 10 : Cardiovascular

16:15 • 159 • Immune checkpoint inhibitors and cardiovascular adverse events - A real-world analysis of cardiovascular adverse events in cancer patients treated with immune checkpoint inhibitors > L. Lauriane Benoist 16:21 • 125 • Safety Profile of Biologic Therapies in Severe Asthma: An Observational Study Based on the French Pharmacovigilance Database > A. Aurélie GRANDVUILLEMIN 16:27 • 278 • Fenfluramine (Fintepla) associated pulmonary arterial hypertension (PAH) : a study of adverse events reporting systems FAERS > C. Coline BROSSAT 16:33 • 500 • Impact of salt intake on blood pressure during treatment with bevacizumab > M. Morgane CHAMBOUX 16:39 • 406 • Molecular-level characterization of the binding mode of the four stereoisomers of prasugrel active metabolite with its target, the P2Y12 receptor > J. JENNIFER LAGOUTTE-RENOSI